A clinical research site focused on neurological diseases at Mayo Clinic
Official title: The Mayo Clinic NeuroNEXT Clinical Research Site
Funded at Mayo Clinic Rochester · NIH-10888401 · Data updated 2026-11-12
This study at Mayo Clinic is looking to improve clinical trials for people with neurological diseases, giving patients a chance to join exciting new trials that could lead to better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | July 15, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $435,680 |
| NIH project number | 5U24NS133986-02 |
| Project ID | NIH-10888401 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals of all ages with neurological disorders, particularly those with rare or ultra-rare conditions.
✕Less likely to help
Patients with common neurological conditions that are already well-studied may not receive significant benefits from this research.
What this research studies
This research initiative at Mayo Clinic aims to enhance clinical trials for neurological diseases by leveraging its extensive network of child and adult neurologists and state-of-the-art facilities across multiple locations. The program will support innovative clinical trial activities and provide training for future clinical trialists. By integrating various resources and expertise, the research seeks to address unmet needs in patient populations suffering from neurological disorders. Patients may have the opportunity to participate in cutting-edge trials that could lead to new treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with neurological diseases.
How similar studies have gone: Previous research initiatives at Mayo Clinic have demonstrated success in advancing treatment options for various neurological conditions, indicating a strong potential for this approach.
Where this research is happening
-
Mayo Clinic Rochester
Rochester, United States Active
Researchers
- Principal investigator: Staff, Nathan P — Mayo Clinic Rochester
- Study coordinator: Staff, Nathan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.